Clinical usefulness of 99mTc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: A preliminary communication

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 10, 2003, Pages 1402-1406

  Płachcińska, Anna ^a   Mikołajczak, Renata ^b   Maecke, Helmut R ^c   Młodkowska, Ewa ^a   Kunert Radek, Jolanta ^a   Michalski, Andrzej ^d   Rzeszutek, Katarzyna ^d   Kozak, Józef ^e   Kuśmierek, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b SOLTAN INSTITUTE FOR NUCLEAR STUDIES   (Poland)

^c Kantonspital Basel   (Switzerland)

^d Ctr for Treatm of Pulmon Diseases   (Poland)

^e N Copernicus Hospital   (Poland)

Author keywords

Lung cancer; Octreotide; Receptor scintigraphy; Somatostatin analogue; Tumour targeting

Indexed keywords

CORTICOTROPIN; ETHYLENEDIAMINEDIACETIC ACID; HYDRAZINONICOTINYLOCTREOTIDE[3 TYROSINE] TC 99M; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; TECHNETIUM 99M EDDA HYNIC TYR(3) OCTREOTIDE; TECHNETIUM 99M EDDA-HYNIC-TYR(3)-OCTREOTIDE; TECHNETIUM COMPLEX;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CARCINOID; CLINICAL ARTICLE; CORTICOTROPIN RELEASE; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; IMAGING; LEIOMYOSARCOMA; LIPOSARCOMA; LUNG CANCER; MALE; MELANOMA; METASTASIS; PANCREAS CARCINOMA; PHEOCHROMOCYTOMA; PILOT STUDY; PROSTATE CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHOLE BODY SCINTISCANNING; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METHODOLOGY; MIDDLE AGED; NEOPLASM; QUALITY CONTROL; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ORGANOTECHNETIUM COMPOUNDS; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; QUALITY CONTROL; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 17744407080     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1254-6     Document Type: Article

References (16)

1. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20:716-731.
2. Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001; 28:836-846.
3. Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Maecke H. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin tracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000; 27:273-282.
4. Kwekkeboom DJ, Krenning EP. Somatostatin receptor imaging. Semin Nucl Med 2002; 32:84-91.
5. Vallabhajosula S, Moyer BR, Lister-James J, McBride WJ, Lipszyc H, Lee H, Bastidas D, Dean RT. Preclinical evaluation of technetium-99m-labeled somatostatin receptor binding peptides. J Nucl Med 1996; 37:1016-1022.
6. Maecke HR, Béhé M. New octreotide derivatives labelled with technetium-99m [abstract]. J Nucl Med 1996; 37:1144.
7. 111In-octreotide. J Nucl Med 2000; 41:1114-1119.
8. 111In-labelled octreotide derivatives. Eur J Nucl Med 2000; 27:1318-1325.
9. Reubi JC, Waser B, Sheppard M, Macaulay V. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors. Int J Cancer 1990; 45:269-274.
10. Sagman U, Mullen JB, Kovacs K, Kerbel R, Ginsberg R, Reubi JC. Identification of somatostatin receptors in human small cell lung carcinoma. Cancer 1990; 66:2129-2133.
11. Kwekkeboom DJ, Kho GS, Lamberts SWJ, Reubi CJ, Laissue JA, Krenning EP. The value of octrotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994; 21:1106-1113.
12. O'Byrne KJ, Halmos G, Pinski J, Groot K, Szepeshazi K, Schally AV, Carney DN. Somatostatin receptor expression in lung cancer. Eur J Cancer 1994; 30A:1682-1687.
13. 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung. J Nucl Med 2001; 42:1309-1315.
14. 99mTc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000; 117:1232-1238.
15. Van der Harst E, de Herder WW, Bruining HA. [(123)I]Meta-iodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 2001; 86:685-693.
16. Hoefnagel CA, Rankin EM, Valdes O. Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide. Eur J Nucl Med 1994; 21:587-588.